EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy

Jagoda Pokryszka iD, Martina Wichlas, Harald Vogelsang, Michael Trauner, Merima Herac-Kornauth, Lili Kazemi-Shirazi

Zeitschrift für Gastroenterologie · 01.03.2024 · 62 (03) · 404-406

DOI: 10.1055/a-2079-6445 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.03.2024. Verfasst von Jagoda Pokryszka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Medical University of Vienna, Wien, Austria. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present here a case of a 39-year-old patient who presented with celiac-disease-like symptoms and MARSH 3a histology in duodenal biopsies under normal diet. Interestingly, HLA genotyping and celiac-specific serology were negative, primarily leading to exclusion of celiac disease. However, biopsies from a second endoscopy a couple of months later (still under normal diet) showed histologic progression of the disease to MARSH 3b and led to the re-evaluation of the out-of-hospital-obtained histological samples by a pathologist experienced in celiac disease. The second biopsy described previously as MARSH 3b turned out to be non-specific and was therefore re-classified as MARSH 0. After all known causes of duodenal villous atrophy were excluded by a thorough evaluation, a correlation between the first biopsy (MARSH 3a) and Truvada intake could be established. After Truvada discontinuation and under normal diet, normalisation of duodenal mucosa was observed, leading to the assumption that Truvada could lead to celiac-like enteropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseHumansAdultEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationEmtricitabineTenofovirDuodenumBiopsyIntestinal Mucosa

Substanzen

Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationEmtricitabineTenofovir

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Medical University of Vienna, Wien, Austria.
  • Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Gruppenpraxis Interne Donaustadt, Vienna, Austria.
  • Clinical Institute of Pathology, Medical University of Vienna, Wien, Austria.

ORCID-Profile: Jagoda Pokryszka

Zitieren

APA

Pokryszka, J., Wichlas, M., Vogelsang, H., Trauner, M., Herac-Kornauth, M., & Kazemi-Shirazi, L. (2024). Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy. Zeitschrift für Gastroenterologie, 62(03), 404-406. https://doi.org/10.1055/a-2079-6445

Vancouver

Pokryszka J, Wichlas M, Vogelsang H, Trauner M, Herac-Kornauth M, Kazemi-Shirazi L. Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy. Zeitschrift für Gastroenterologie. 2024;62(03):404-406. doi:10.1055/a-2079-6445

BibTeX
@article{Pokryszka2024,
  author = {Pokryszka, Jagoda and Wichlas, Martina and Vogelsang, Harald and Trauner, Michael and Herac-Kornauth, Merima and Kazemi-Shirazi, Lili},
  title = {Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {03},
  pages = {404--406},
  doi = {10.1055/a-2079-6445}
}
Kostenlos starten →